all AI news
DEEMD: Drug Efficacy Estimation against SARS-CoV-2 based on cell Morphology with Deep multiple instance learning. (arXiv:2105.05758v2 [cs.LG] UPDATED)
Web: http://arxiv.org/abs/2105.05758
June 17, 2022, 1:13 a.m. | M.Sadegh Saberian, Kathleen P. Moriarty, Andrea D. Olmstead, Christian Hallgrimson, François Jean, Ivan R. Nabi, Maxwell W. Libbrecht, Ghassan Ha
cs.CV updates on arXiv.org arxiv.org
Drug repurposing can accelerate the identification of effective compounds for
clinical use against SARS-CoV-2, with the advantage of pre-existing clinical
safety data and an established supply chain. RNA viruses such as SARS-CoV-2
manipulate cellular pathways and induce reorganization of subcellular
structures to support their life cycle. These morphological changes can be
quantified using bioimaging techniques. In this work, we developed DEEMD: a
computational pipeline using deep neural network models within a multiple
instance learning framework, to identify putative treatments effective …
More from arxiv.org / cs.CV updates on arXiv.org
Latest AI/ML/Big Data Jobs
Machine Learning Researcher - Saalfeld Lab
@ Howard Hughes Medical Institute - Chevy Chase, MD | Ashburn, Virginia
Project Director, Machine Learning in US Health
@ ideas42.org | Remote, US
Data Science Intern
@ NannyML | Remote
Machine Learning Engineer NLP/Speech
@ Play.ht | Remote
Research Scientist, 3D Reconstruction
@ Yembo | Remote, US
Clinical Assistant or Associate Professor of Management Science and Systems
@ University at Buffalo | Buffalo, NY